The pharmacokinetics and safety of idelalisib in subjects with moderate or severe hepatic impairment

E-ISSN： 1552-4604|55|8|944-952

ISSN： 0091-2700

Source： JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.55, Iss.8, 2015-08, pp. : 944-952

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The pharmacokinetics and safety of darapladib in subjects with severe renal impairment

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 4, 2015-10 ,pp. : 654-661

John Wiley & Sons Inc

Access to resources Recommend Favorite

The pharmacokinetics and safety of darapladib in subjects with severe renal impairment

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 306-5251, Iss. 4, 2015-10 ,pp. : 654-661

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics of bound and unbound telaprevir in cirrhotic patients with moderate and severe hepatic impairment

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 10, 2015-10 ,pp. : 1147-1156

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics of Nintedanib in Subjects With Hepatic Impairment

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 58, Iss. 3, 2018-03 ,pp. : 357-363

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics of a single dose of the antifungal posaconazole as oral suspension in subjects with hepatic impairment

By Moton Allen Krishna Gopal Ma Lei O’Mara Edward Prasad Pratapa McLeod James Preston Richard A.

Current Medical Research and Opinion, Vol. 26, Iss. 1, 2010-01 ,pp. : 1-7

Informa Healthcare

Access to resources Recommend Favorite